Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Edward J Meier, Gail L Torkildsen, Paul J Gomes & Mark C Jasek. (2018) Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model. Clinical Ophthalmology 12, pages 2617-2628.
Read now
Read now
Articles from other publishers (4)
Najam A. Sharif. 2022. Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics. Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics
403
422
.
Rohan Bir Singh, Lingjia Liu, Ann Yung, Sonia Anchouche, Sharad K. Mittal, Tomas Blanco, Thomas H. Dohlman, Jia Yin & Reza Dana. (2021) Ocular redness – II: Progress in development of therapeutics for the management of conjunctival hyperemia. The Ocular Surface 21, pages 66-77.
Crossref
Crossref
Najam A. Sharif. (2020) Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810. ACS Pharmacology & Translational Science 3:6, pages 1391-1421.
Crossref
Crossref
Samah Kandeel & Mohamed Balaha. (2018) Olopatadine enhances recovery of alkali-induced corneal injury in rats. Life Sciences 207, pages 499-507.
Crossref
Crossref